Intraprocedural abciximab bolus versus pretreatment oral dual antiplatelet medication for endovascular stenting of unruptured intracranial aneurysms.

about

Acute rerupture after coil embolization of ruptured intracranial saccular aneurysms: A literature review.

P2860

Q47920362-85728063-E08B-4CE3-BEC7-0C840EE2D093

P2860

Intraprocedural abciximab bolus versus pretreatment oral dual antiplatelet medication for endovascular stenting of unruptured intracranial aneurysms.

Item

http://www.wikidata.org/entity/Q38422590

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intraprocedural abciximab bolu ...... ptured intracranial aneurysms.

@en

type

Item

label

Intraprocedural abciximab bolu ...... ptured intracranial aneurysms.

@en

prefLabel

Intraprocedural abciximab bolu ...... ptured intracranial aneurysms.

@en

P1476

Intraprocedural abciximab bolu ...... ptured intracranial aneurysms.

@en

P2093

Cameron G McDougall

http://www.w3.org/2001/XMLSchema#string

Celene B Mulholland

http://www.w3.org/2001/XMLSchema#string

Felipe C Albuquerque

http://www.w3.org/2001/XMLSchema#string

Karam Moon

http://www.w3.org/2001/XMLSchema#string

M Yashar S Kalani

http://www.w3.org/2001/XMLSchema#string

Michael R Levitt

http://www.w3.org/2001/XMLSchema#string

P2860

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms

Thrombocytopenia associated with c7E3 Fab (abciximab).

A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.

Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: outcome and fatal hemorrhagic complications.

Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of the literature.

Glycoprotein IIb-IIIa inhibitors.

Anti-thrombotic medications for the neurointerventionist: aspirin and clopidogrel.

Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial.

Critical assessment of complications associated with use of the Pipeline Embolization Device.

P304

909-912

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/NEURINTSURG-2015-011935

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26354945

http://www.w3.org/2001/XMLSchema#string

Intraprocedural abciximab bolus versus pretreatment oral dual antiplatelet medication for endovascular stenting of unruptured intracranial aneurysms.

about

P2860

P2860

Intraprocedural abciximab bolus versus pretreatment oral dual antiplatelet medication for endovascular stenting of unruptured intracranial aneurysms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698